袁宇峰


【摘要】目的 探索厄贝沙坦氢氯噻嗪片与苯磺酸氨氯地平片治疗高血压病的疗效和经济价值。
方法 选取本院2014年1月~2016年7月在我院治疗的患者78例,将其随机分为A组和B组,每组39例。A组患者给予厄贝沙坦氢氯噻嗪片进行治疗,B组患者给予苯磺酸氨氯地平片进行治疗。比较两组患者在治疗后的疗效和药物的经济价值。结果 厄贝沙坦氢氯噻嗪片的经济价值较苯磺酸氨氯地平片高。A、B两组患者在用药后的疗效比较差异有统计学意义(x2=10.067,P<0.05),B组患者的疗效明显较A组低。结论 使用厄贝沙坦氢氯噻嗪片治疗高血压患者的疗效较使用苯磺酸氨氯地平片好,且更经济,可以在临床上推广应用。
【关键词】厄贝沙坦氢氯噻嗪片;苯磺酸氨氯地平片;高血压
【中图分类号】R544.1 【文献标识码】B 【文章编号】ISSN.2095-6681.2016.35.0.02
【Abstract】Objective To explore the effect and economic value of irbesartan and hydrochlorothiazide tablets and amlodipine besylate tablets in treatment of hypertensive diseases.Methods In total 79 cases,who were admitted in our hospital during January 2014 and July 2016,were selected and divided randomly into group A and group B, with 39 cases in each group.Patients in group A received irbesartan and hydrochlorothiazide tablets and patients in group B received amlodipine besylate tablets.The curative effect and the economic value of two groups were compared.Results The economic value of irbesartan and hydrochlorothiazide tablets was higher than amlodipine besylate tablets.The curative effect comparison between two groups had significant difference(x2=10.067,P=0.007);the curative effect of patients in group B was significantly lower than that of group A.Conclusion The curative effect of irbesartan and hydrochlorothiazide tablets is better than amlodipine besylate tablets in treatment of hypertensive diseases and it has better economic value. It should be popularized in clinical application.
【Key words】Irbesartan and hydrochlorothiazide tablets;Amlodipine besylate tablets;Hypertension
高血压疾病是多种病因引起的心血管疾病综合征,将可能引起患者心血管结构和功能的变化,使患者的肾功能和心功能受到损害,严重危及患者的生命安全和健康状态[1]。近年来,我国高血压病的发病率正在逐年增加,且越来越年轻化。因此,寻求有效的治疗药物和治疗方法就成了一个急需解决的问题,目前临床上用于治疗高血压的药物有复方制剂与单一制剂,常用的有厄贝沙坦氢氯噻嗪片与苯磺酸氨氯地平片[2]。本研究就探索了使用这两种药物治疗高血压时的疗效和药物的经济价值,还对这两种药物的治療过程和结果汇报如下。
1 资料与方法
1.1 一般资料……p>